Processing

Please wait...

Settings

Settings

Goto Application

1. WO2010031361 - A COMPOSITION WITH INHIBITION ACTIVITY ON PATHOLOGICAL ANGIOGENESIS

Publication Number WO/2010/031361
Publication Date 25.03.2010
International Application No. PCT/CN2009/074086
International Filing Date 22.09.2009
IPC
A61K 38/19 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
A61P 35/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
A61K 38/1808
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
18Growth factors; Growth regulators
1808Epidermal growth factor [EGF] urogastrone
A61K 38/1833
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
18Growth factors; Growth regulators
1833Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
A61K 38/1858
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
18Growth factors; Growth regulators
1858Platelet-derived growth factor [PDGF]
A61K 38/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 1/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
16for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Applicants
  • 台湾东洋药品工业股份有限公司 TTY BIOPHARM COMPANY LIMITED [CN]/[CN] (AllExceptUS)
  • 郭明良 KUO, Min-Liang [CN]/[CN] (UsOnly)
  • 吴玉琳 WU, Yu-Ling [CN]/[CN] (UsOnly)
Inventors
  • 郭明良 KUO, Min-Liang
  • 吴玉琳 WU, Yu-Ling
Agents
  • 北京市柳沈律师事务所 LIU, SHEN & ASSOCIATES
Priority Data
61/136,63522.09.2008US
Publication Language Chinese (zh)
Filing Language Chinese (ZH)
Designated States
Title
(EN) A COMPOSITION WITH INHIBITION ACTIVITY ON PATHOLOGICAL ANGIOGENESIS
(FR) COMPOSÉ MÉDICINAL AYANT UN EFFET INHIBANT SUR LES VAISSEAUX SANGUINS PATHOLOGIQUES
(ZH) 抑制病理性血管发生作用的组合物
Abstract
(EN) A pharmaceutical composition with inhibition activity on pathological angiogenesis and/or histiocytosis is provided in the invention. The pharmaceutical composition includes an effective amount of LECT2 proteins or derivatives thereof and a pharmaceutically acceptable carrier.
(FR) L’invention concerne un composé médicinal ayant un effet inhibant sur les vaisseaux sanguins pathologiques et/ou la prolifération de cellule. Ledit composé médicinal comprend une quantité significative de protéines LECT2 ou d’une substance similaire et un transporteur pharmaceutiquement acceptable.
Latest bibliographic data on file with the International Bureau